The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Wondfo at MEDICA on Nov.16-19, many wonderful things await you!
November 16,2020 (Edit) Wondfo
Exhibition: virtual.MEDICA Date: November 16-19 Wondfo eBooth: https://virtual.medica-tradefair.com/vis/v1/en/exhibitors/medcom2020.2663050?oid=118031&lang=2
Dear friends,
MEDICA, the world’s largest event for the medical sector, takes place as a virtual exhibition on November 16-19. Wondfo, as a regular exhibitor at MEDICA, still shows up at the event with new solutions and innovations.
Wondfo sincerely welcomes you to visit our eBooth to have deep communication on our products and solutions with our team via phone, online video…during the exhibition.
What’s Wondfo going to present to you at the exhibition? Here are some hints: Wondfo’s comprehensive COVID-19 diagnostic solution, 1 ㎡ POCT lab, new product…
Wondfo, a fast-growing POCT leader in China, has been focusing on the R&D, production, sales, and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions since founded in 1992.
We look forward to meeting you at the exhibition and hope to establish a long-term business relationship with your company in the near future.